Table 2. Absolute risk of death by 28 days, SARS-CoV-2 VOC vs non-VOC infection, England, 16 November 2020–5 February (n =112,979).
Sex | Age group (years) | Non-VOC | VOC | ||
---|---|---|---|---|---|
% | 95% CI | % | 95% CI | ||
No comorbidities | |||||
Female n = 52,718 |
0– < 65 | 0.05 | 0.03–0.06 | 0.07 | 0.06–0.09 |
65– < 75 | 0.45 | 0.30–0.59 | 0.72 | 0.50–0.95 | |
75– < 85 | 1.08 | 0.71–1.45 | 1.73 | 1.15–2.31 | |
≥ 85 | 2.36 | 1.47–3.25 | 3.75 | 2.34–5.16 | |
Male n = 42,724 |
0– < 65 | 0.09 | 0.07–0.11 | 0.14 | 0.11–0.17 |
65– < 75 | 0.85 | 0.59–1.12 | 1.37 | 0.96–1.77 | |
75– < 85 | 2.03 | 1.35–2.71 | 3.24 | 2.19–4.30 | |
≥ 85 | 4.38 | 2.72–6.03 | 6.87 | 4.33–9.42 | |
One comorbidity | |||||
Female n = 6,858 |
0– < 65 | 0.11 | 0.08–0.15 | 0.18 | 0.13–0.24 |
65– < 75 | 1.09 | 0.78–1.41 | 1.75 | 1.25–2.25 | |
75– < 85 | 2.60 | 1.84–3.35 | 4.13 | 2.94–5.32 | |
≥ 85 | 5.54 | 3.77–7.31 | 8.64 | 5.91–11.38 | |
Male n = 6,661 |
0– < 65 | 0.22 | 0.15–0.28 | 0.35 | 0.25–0.45 |
65– < 75 | 2.06 | 1.51–2.62 | 3.29 | 2.44–4.14 | |
75– < 85 | 4.81 | 3.48–6.14 | 7.54 | 5.52–9.55 | |
≥ 85 | 9.94 | 6.87–13.01 | 15.10 | 10.63–19.58 | |
Two or more comorbidities | |||||
Female n = 1,921 |
0– < 65 | 0.21 | 0.14–0.28 | 0.34 | 0.22–0.45 |
65– < 75 | 1.99 | 1.41–2.57 | 3.18 | 2.27–4.09 | |
75– < 85 | 4.66 | 3.45–5.87 | 7.31 | 5.42–9.20 | |
≥ 85 | 9.65 | 7.01–12.29 | 14.68 | 10.73–18.63 | |
Male n = 2,097 |
0– < 65 | 0.40 | 0.27–0.52 | 0.64 | 0.44–0.84 |
65– < 75 | 3.72 | 2.74–4.69 | 5.87 | 4.38–7.35 | |
75– < 85 | 8.44 | 6.44–10.44 | 12.93 | 9.99–15.87 | |
≥ 85 | 16.65 | 12.42–20.88 | 24.34 | 18.55–30.13 |
Absolute risk is calculated from the marginal means of a fully adjusted logistic regression model with outcome death by 28 days after positive test for SARS-CoV-2, restricted to the population with a minimum of 28 days from testing to the follow-up censor. Deaths beyond 28 days were censored. The fully adjusted model includes adjustment for: age, sex, index of multiple deprivation, ethnicity, smoking status, obesity, household size, NHS England region, rural/urban classification, comorbidities, epidemiological week and care home status.